(Press-News.org) ORLANDO, Fla. — Breast cancer survivors with poor physical health scores had an elevated risk of poorer cancer outcomes, including recurrence and death, according to the results of an observational study presented at the AACR 102nd Annual Meeting 2011, held April 2-6.
Survivors of breast cancer who had poor health scores were 27 percent more likely to experience either a recurrence of their cancer or a new breast cancer. Physical health also impacted survival quite strongly; risk of death from any cause was 65 percent greater among those with poorer health scores.
Researchers from UC San Diego Moores Cancer Center used data from three of the four cohorts included in the After Breast Cancer (ABC) Pooling Project to analyze the association of poor physical health and survival, along with a cluster of comorbidities. The physical health score has been shown in smaller studies to be an important predictor of future breast cancer events and overall survival in women with breast cancer.
"Here we see a single metric that predicts risk," said John P. Pierce, Ph.D., who is the Sam M. Walton professor for cancer prevention and associate director for population sciences at Moores Cancer Center. "Variables cluster together and are summarized in the physical health score. The question becomes how to improve the physical health status of this particular group of breast cancer survivors."
Physical health scores were measured for a total of 9,387 early-stage breast cancer survivors, using the SF-36 – a multipurpose, short-form health survey taken after diagnosis, with follow-up occurring on average seven years later. The physical health score includes information about how an individual perceives their own physical functioning, bodily pain and limitations caused by physical problems.
About half the women in the sample had a physical health score that met the survey definition of poor physical health. Low physical health scores were strongly associated with a higher body mass index. The women with low scores were less physically active and were 64 percent more likely to have sleep difficulties. They also had 50 percent higher rates of high blood pressure and diabetes and were twice as likely to have arthritis.
By addressing this cluster of health concerns, clinicians can help women improve their health, feel better about their lives and reduce associated breast cancer risks, according to Pierce.
"Instead of looking at breast cancer survivors as a whole, we need to focus on the women with low physical health scores, those most at risk," he said. "An increase of 5 percent in their physical health score can reduce their risk. We can empower them to take charge of their health and thereby improve their chance of survival as well as their quality of life."
###
Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: http://www.aacr.org/PressRegistration
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.
Physical health scores predict breast cancer outcomes
2011-04-07
ELSE PRESS RELEASES FROM THIS DATE:
Strawberries may slow precancerous growth in esophagus
2011-04-07
ORLANDO, Fla. — Freeze-dried strawberries may be an alternative to drugs for the prevention of esophageal cancer, according to research presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.
"We concluded from this study that six months of eating strawberries is safe and easy to consume. In addition, our preliminary data suggests that strawberries can decrease histological grade of precancerous lesions and reduce cancer-related molecular events," said lead researcher Tong Chen, M.D., Ph.D., assistant professor, division of medical oncology, department ...
Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen
2011-04-07
ORLANDO, FL (April 6, 2011) – Breast cancer is the second most common cancer among women, with more than 200,000 women diagnosed each year. Being exposed to estrogen over a long period of time is one factor that can increase a woman's risk of developing the disease. One way a woman can combat this risk factor is by taking the breast cancer drug tamoxifen, which interferes with the activity of estrogen. Now, researchers at Fox Chase Cancer Center have found that omega-3 fatty acids—abundant in fish—could be a safe and beneficial booster for tamoxifen therapy.
Jose Russo, ...
Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer
2011-04-07
ORLANDO, FL (April 6, 2011) – Numerous studies show that non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of colon cancer. However, animal studies testing the NSAID naproxen or its derivative, NO-naproxen, have focused primarily on chemically-induced tumor formation. Now, researchers at Fox Chase Cancer Center find that naproxen and NO-naproxen reduce tumor formation in a strain of mutant mice that spontaneously develop colon tumors. The data also suggest that naproxen blocks a gatekeeper step that initiates tumor formation.
Margie Clapper, PhD, Co-Leader ...
Healthy welders may be at increased risk for early brain damage
2011-04-07
New research suggests that workers exposed to welding fumes may be at risk for developing brain damage in an area of the brain also affected in Parkinson's disease. The study is published in the April 6, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Fumes produced by welding contain manganese. Manganese is a chemical element that, even at low levels, has been linked to neurologic problems, including Parkinson's disease-like symptoms.
"There are over one million workers who perform welding as part of their job functions ...
Genetic variants associated with caffeine intake identified
2011-04-07
Two genes in which variation affects intake of caffeine, the most widely consumed stimulant in the world, have been discovered. A team of investigators from the National Cancer Institute, Harvard School of Public Health, Brigham and Women's Hospital, and the University of North Carolina at Chapel Hill examined genetic variation across the entire genome of more than 47,000 individuals from the U.S., as described in the open-access journal PLoS Genetics.
The genes identified were CYP1A2, which has previously been implicated in the metabolism of caffeine, and AHR, involved ...
An international study in China finds strawberries may slow precancerous growth in the esophagus
2011-04-07
COLUMBUS, Ohio – Eating strawberries may be a way to help people at risk of esophageal cancer protect themselves from the disease, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and researchers in China.
Dr. Tong Chen will present the findings during a press briefing at 8 a.m. April 6 at the American Association for Cancer Research (AACR) 102nd meeting 2011 in Orlando, Fla. The study is the first-ever collaborative Ohio State cancer ...
Placing value, price on new drugs: The challenge facing new UK policy, say Hopkins bioethicists
2011-04-07
The United States should pay close attention to how the United Kingdom carries out plans to assess a new drug's worth using factors that go beyond clinical and cost effectiveness, according to researchers at the Johns Hopkins Berman Institute of Bioethics.
In a commentary to appear in the April 7 issue of the New England Journal of Medicine, the bioethicists detail and discuss a new, "value-based pricing" policy proposed by the British government. Up to now, companies have been able to price their drugs freely. But if the new policy is implemented, the U.K. will start ...
NYU Cancer Institute experts present at the AACR 102nd Annual Meeting 2011
2011-04-07
Experts from The Cancer Institute at NYU Langone Medical Center presented new research findings at the American Association for Cancer Research 102nd Annual Meeting 2011 held April 2-6, 2011 in Orlando, Florida. NYU Cancer Institute researchers discussed various breakthroughs such as a novel test for early-stage asbestos-related pulmonary cancer, a promising treatment strategy for glioblastomas, genome-wide mapping of nickel-related cancer and greater understanding of melanoma and bladder cancer.
Detection of Mesothelioma in Asbestos Exposed Individuals with Aptamer ...
Trion:Z Announces Masters Tournament Active Series Contest
2011-04-07
To participate in the Trion:Z Masters Tournament giveaway contest, all you have to do is pick which of the three Rs is going to win. Trion:Z's triple threat; Rickie Fowler, Rory Mc Ilroy and Ryo Ishikawa - all will be competing for the coveted green jacket. Each possess the skill, talent, and drive to be the next Masters Champion.
According to Reuters' Mark Lamport-Stokes, "Mc Ilroy long regarded as a future world #1 is probably the most spectacular member of the emerging generation to watch." However, Ishikawa is playing for the pride of Japan and is donating his 2011 ...
UPCI, Pitt researchers present findings of cancer studies at AACR 102nd Annual Meeting
2011-04-07
Orlando, Fla. – How do certain multiple myeloma treatment drugs cause complications? How does the immune system become dysfunctional due to cancer? How safe is a vaccine that could prevent development of precancerous colon polyps? Those are among the many questions that will be answered by researchers from the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine during the American Association for Cancer Research 102nd Annual Meeting 2011, April 2 to 6, in Orlando, Fla.
UPCI and Pitt researchers will present more than 80 ...